CSIRO is mounting a major display of technologies this week at BIO 2004, the world's largest biotechnology conference, being held in San Francisco, USA, from 6-9 June.
CSIRO research being featured includes:
- Drug Discovery and Development - cutting edge structural biology, rational drug design, and protein engineering
- Therapeutic Delivery - better, more efficient ways to speed drugs to their targets
- Gene Silencing and related techniques - powerful new gene technologies to enhance therapies and control plant and animal breeding
- Diagnostics - new approaches to infectious disease identification
- Biomaterials and Tissue Engineering - novel materials for cartilage repair, collagen technologies, biopolymers.
- Bioprocessing and Functional Foods - production of high value chemicals for the food, pharmaceutical and other industries
- Bioinformatics - sophisticated statistical analysis of complex data sets generated in biotechnology.
"This is the sixth time we have showcased our research at BIO," said Dr Mikael Hirsch, Biotechnology Strategy Coordinator for CSIRO.
"This year we are highlighting our Commercial Opportunities in the Life Sciences," Dr Hirsch added. "It is important that our world class science leads to commercial outcomes for global benefit".
Minister for Industry, Tourism and Resources, The Hon Ian MacFarlane MP, will lead the Australian delegation. The CSIRO delegation of 11 includes senior executives, scientists and business managers.
"The attendance at BIO of a Federal Minister and the Premiers of Victoria, NSW and Queensland underlines the importance Australia places on our international profile in this rapidly moving business and scientific field." said Dr Hirsch.